Literature DB >> 10938133

Associations and interactions between bare lymphocyte syndrome factors.

A M DeSandro1, U M Nagarajan, J M Boss.   

Abstract

The bare lymphocyte syndrome, a severe combined immunodeficiency due to loss of major histocompatibility complex (MHC) class II gene expression, is caused by inherited mutations in the genes encoding the heterotrimeric transcription factor RFX (RFX-B, RFX5, and RFXAP) and the class II transactivator CIITA. Mutagenesis of the RFX genes was performed, and the properties of the proteins were analyzed with regard to transactivation, DNA binding, and protein-protein interactions. The results identified specific domains within each of the three RFX subunits that were necessary for RFX complex formation, including the ankyrin repeats of RFX-B. DNA binding was dependent on RFX complex formation, and transactivation was dependent on a region of RFX5. RFX5 was found to interact with CIITA, and this interaction was dependent on a proline-rich domain within RFX5. Thus, these studies have defined the protein domains required for the functional regulation of MHC class II genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938133      PMCID: PMC86141          DOI: 10.1128/MCB.20.17.6587-6599.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

Review 1.  Major histocompatibility complex class II deficiency: a clinical review.

Authors:  R Elhasid; A Etzioni
Journal:  Blood Rev       Date:  1996-12       Impact factor: 8.250

2.  Protein family classification based on searching a database of blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Genomics       Date:  1994-01-01       Impact factor: 5.736

Review 3.  MHC class II-deficient combined immunodeficiency: a disease of gene regulation.

Authors:  B Mach; V Steimle; W Reith
Journal:  Immunol Rev       Date:  1994-04       Impact factor: 12.988

4.  Class II MHC transcriptional mutants are defective in higher order complex formation.

Authors:  J L Riley; J M Boss
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

5.  The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation.

Authors:  H Xiao; J T Lis; H Xiao; J Greenblatt; J D Friesen
Journal:  Nucleic Acids Res       Date:  1994-06-11       Impact factor: 16.971

6.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

Authors:  V Steimle; C A Siegrist; A Mottet; B Lisowska-Grospierre; B Mach
Journal:  Science       Date:  1994-07-01       Impact factor: 47.728

7.  Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.

Authors:  H Zhou; L H Glimcher
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

8.  Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA).

Authors:  J L Riley; S D Westerheide; J A Price; J A Brown; J M Boss
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

9.  A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).

Authors:  V Steimle; B Durand; E Barras; M Zufferey; M R Hadam; B Mach; W Reith
Journal:  Genes Dev       Date:  1995-05-01       Impact factor: 11.361

10.  Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.

Authors:  C H Chang; J D Fontes; M Peterlin; R A Flavell
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  40 in total

1.  Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains.

Authors:  M W Linhoff; J A Harton; D E Cressman; B K Martin; J P Ting
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  Self-association of CIITA and its transactivation potential.

Authors:  T J Sisk; S Roys; C H Chang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.

Authors:  G Li; J A Harton; X Zhu; J P Ting
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

4.  Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.

Authors:  Krzysztof Masternak; Walter Reith
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

5.  Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

Authors:  M Peretti; J Villard; E Barras; M Zufferey; W Reith
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.

Authors:  Wojciech Wiszniewski; Marie-Claude Fondaneche; Pascale Louise-Plence; Ada Prochnicka-Chalufour; Françoise Selz; Cappucine Picard; Françoise Le Deist; Jean-François Eliaou; Alain Fischer; Barbara Lisowska-Grospierre
Journal:  Immunogenetics       Date:  2003-01-16       Impact factor: 2.846

7.  CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II.

Authors:  Charalambos Spilianakis; Androniki Kretsovali; Theodora Agalioti; Takis Makatounakis; Dimitris Thanos; Joseph Papamatheakis
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 8.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 9.  The ankyrin repeat as molecular architecture for protein recognition.

Authors:  Leila K Mosavi; Tobin J Cammett; Daniel C Desrosiers; Zheng-Yu Peng
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

10.  Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.

Authors:  Priya Londhe; Judith K Davie
Journal:  Sci Signal       Date:  2013-12-10       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.